Fund Holdings — JOHNSON & JOHNSON

Total Portfolio Value
$341.87M
Total Bought
$0
Total Sold
$0
Net Transaction
$0
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Protagonist Therapeutics Inc.2,449,1832,449,183094,538118,44234.65%+23,904
MeiraGTx Holdings plc(MGTX)6,641,0646,641,064040,44445,02613.17%+4,582
Nanobiotix S.A.(NBTX)5,623,8165,623,816016,14020,1335.89%+3,993
Legend Biotech Corporation(LEGN)814,586814,586026,50727,6398.08%+1,132
Senseonics Holdings, Inc.(SENS)54,62154,621029360.01%+7
BiomX Inc.(PHGE)96,86696,866071540.02%-17
Adicet Bio, Inc.364,472364,47203512750.08%-75
Lyell Immunopharma Inc.(LYEL)823,317823,31705274430.13%-84
Standard BioTools Inc(LAB)311,967311,96705463370.10%-209
Nano-X Imaging Ltd.
ORD SHS
158,852158,85201,1447930.23%-350
Vor Biopharma, Inc.(VOR)1,074,6581,074,65801,1937710.23%-422
Rallybio Corporation(RLYB)3,636,3633,636,36303,4912,3800.70%-1,111
Arrowhead Pharmaceuticals, Inc.(ARWR)247,598247,59804,6553,1540.92%-1,500
CVRx, Inc.(CVRX)4,103,4304,103,430051,99050,18514.68%-1,806
Fate Therapeutics, Inc.(FATE)3,379,0643,379,06405,5752,6700.78%-2,906
Procept BioRobotics Corporation(PRCT)357,939357,939028,82120,8546.10%-7,968
Xencor, Inc.(XNCR)748,062748,062017,1907,9592.33%-9,231
Contineum Therapeutics Inc.(CTNM)1,979,1731,979,173028,99513,8154.04%-15,180
Neumora Therapeutics, Inc.(NMRA)1,849,4451,849,445019,6041,8490.54%-17,755
Rapport Therapeutics, Inc.(RAPP)2,498,0512,498,051044,31525,0557.33%-19,260
Page 1 of 1
JOHNSON & JOHNSON — 13F Holdings — Q1 2025 | TickerTrail